[HTML][HTML] Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort …

V Fanelli, M Giani, G Grasselli, F Mojoli, G Martucci… - Critical Care, 2022 - Springer
Background Extracorporeal membrane oxygenation (ECMO) has become an established
rescue therapy for severe acute respiratory distress syndrome (ARDS) in several etiologies …

[HTML][HTML] Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris

M Schmidt, E Langouet, D Hajage, SA James… - Critical Care, 2021 - Springer
Background Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …

[HTML][HTML] Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis

K Ramanathan, K Shekar, RR Ling, RP Barbaro… - Critical care, 2021 - Springer
Background There are several reports of extracorporeal membrane oxygenation (ECMO)
use in patients with coronavirus disease 2019 (COVID-19) who develop severe acute …

[HTML][HTML] Extracorporeal membrane oxygenation for severe COVID-19-associated acute respiratory distress syndrome in Poland: a multicenter cohort study

E Trejnowska, D Drobiński, P Knapik… - Critical Care, 2022 - Springer
Abstract Background In Poland, the clinical characteristics and outcomes of patients with
COVID-19 requiring extracorporeal membrane oxygenation (ECMO) remain unknown. This …

[HTML][HTML] Outcomes of extracorporeal membrane oxygenation for acute respiratory distress syndrome in COVID-19 patients: a propensity-matched analysis

T Autschbach, N Hatam, K Durak, O Grottke… - Journal of Clinical …, 2021 - mdpi.com
It remains unclear to what extent the outcomes and complications of extracorporeal
membrane oxygenation (ECMO) therapy in COVID-19 patients with acute respiratory …

Extracorporeal membrane oxygenation in patients with COVID-19: an international multicenter cohort study

SJ Raasveld, TSR Delnoij, LM Broman… - Journal of intensive …, 2021 - journals.sagepub.com
Background: To report and compare the characteristics and outcomes of COVID-19 patients
on extracorporeal membrane oxygenation (ECMO) to non-COVID-19 acute respiratory …

[HTML][HTML] Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation

J Herrmann, C Lotz, C Karagiannidis… - Critical Care, 2022 - Springer
Background Severe COVID-19 induced acute respiratory distress syndrome (ARDS) often
requires extracorporeal membrane oxygenation (ECMO). Recent German health insurance …

[HTML][HTML] Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis

RR Ling, K Ramanathan, JJL Sim, SN Wong, Y Chen… - Critical care, 2022 - Springer
Background Extracorporeal membrane oxygenation (ECMO) has been used extensively for
coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) …

Extracorporeal membrane oxygenation for COVID-19–associated severe acute respiratory distress syndrome in Chile: a nationwide incidence and cohort study

RA Diaz, J Graf, JM Zambrano, C Ruiz… - American journal of …, 2021 - atsjournals.org
Rationale: The role of and needs for extracorporeal membrane oxygenation (ECMO) at a
population level during the coronavirus disease (COVID-19) pandemic have not been …

Outcomes of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome caused by COVID-19 versus influenza

E Shih, JJ Squiers, JM DiMaio, T George… - The Annals of Thoracic …, 2022 - Elsevier
Background Extracorporeal membrane oxygenation (ECMO) can be effective for refractory
acute respiratory distress syndrome (ARDS) in patients with influenza, but its utility in …